UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - blood-brain+barrier
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Compounds and Methods for Treating Cancer by Destroying Cancer Stem Cells (UCLA Case No. 2021-286)
Researchers from UCLA’s Department of Chemistry and Biochemistry and the Department of Radiation Oncology have synthesized a set of compounds for the eradication of cancer stem cells. These compounds are predicted to cross the blood brain barrier and show promise as effective interventions for glioblastoma in both in vitro and in vivo assays. BACKGROUND:...
Published: 7/11/2024
|
Inventor(s):
Michael Jung
,
Frank Pajonk
Keywords(s):
blood-brain barrier
,
Brain
,
Cancer
,
Cancer stem cells
,
drug screening
,
GBM
,
Glioblastoma
,
Glioma
,
new chemical entity
Category(s):
Therapeutics > Oncology
,
Therapeutics > CNS and Neurology
,
Therapeutics > Stem Cells And Regenerative Medicine
Development of Novel Compounds to Suppress Neuronal Stress and Cross the Blood Brain Barrier (UCLA Case No. 2021-165)
SUMMARY: An interdisciplinary group of UCLA researchers have developed and validated a library of compounds that alleviate symptoms of Rett Syndrome and hold enormous therapeutic potential for the long-term treatment of other intellectual disability syndromes. BACKGROUND: Intellectual disability (ID) affects more than 100 million people globally and...
Published: 5/8/2024
|
Inventor(s):
William Lowry
,
Michael Jung
,
Xiaoguang Liu
,
Elena Korsakova
Keywords(s):
blood-brain barrier
,
Drug
,
intellectual disability
,
Organoids
,
senescence
Category(s):
Therapeutics > CNS and Neurology
,
Life Science Research Tools
,
Diagnostic Markers > Targets And Assays
Intelligent Stent System for Chronic On-Demand Drug Delivery (Case No. 2021-069)
Summary: UCLA researchers in the Department of Neurology have developed an intelligent stent system for chronic on-demand drug delivery, addressing the challenge of the
blood-brain barrier
hindering drug therapy in the central nervous system. Background: The blood-brain barrier poses a significant obstacle to effective drug delivery to the central...
Published: 7/9/2024
|
Inventor(s):
Jose Morales
,
Haotian Lu
,
Huachen Cui
,
Xiaoyu (Rayne) Zheng
Keywords(s):
blood flow management
,
blood-brain barrier
,
Drug
,
Drug Delivery
,
Drug monitoring
,
Invasiveness Of Surgical Procedures
,
MEMS
,
minimally invasive device
,
minimally invasive drug delivery systems
,
neural signals
,
neural stimulation
,
Neurocognitive
,
Neurodegeneration
,
neurological disorders
,
Neurology
,
neuro-oncology
,
Neuropathology
,
Neurosurgery
,
non-invasive
,
non-invasive drug monitoring
,
on-demand drug delivery
,
Pharmaceutical Drug
,
piezoelectric ultrasound transducers
Category(s):
Platforms
,
Platforms > Drug Delivery
,
Medical Devices
,
Therapeutics
,
Therapeutics > CNS and Neurology
,
Therapeutics > Oncology
,
Therapeutics > Musculoskeletal Disease